{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:55:07Z","timestamp":1790564107531,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG054411"],"award-info":[{"award-number":["AG054411"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04255-4","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:08:13Z","timestamp":1783102093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies"],"prefix":"10.1038","volume":"16","author":[{"given":"Maryline","family":"Santerre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Shcherbik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6034-7343","authenticated-orcid":false,"given":"Bassel E.","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"4255_CR1","unstructured":"WHO. Depressive disorder (depression). Geneva: World Health Organization; 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"key":"4255_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators.","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"4255_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","volume":"4","author":"CJ Harmer","year":"2017","unstructured":"Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017;4:409\u201318.","journal-title":"Lancet Psychiatry"},{"key":"4255_CR4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905\u201317.","journal-title":"Am J Psychiatry"},{"key":"4255_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","volume":"130","author":"L Capuron","year":"2011","unstructured":"Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011;130:226\u201338.","journal-title":"Pharmacol Ther"},{"key":"4255_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"4255_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11920-011-0232-0","volume":"13","author":"CL Raison","year":"2011","unstructured":"Raison CL, Miller AH. Is depression an inflammatory disorder?. Curr Psychiatry Rep. 2011;13:467\u201375.","journal-title":"Curr Psychiatry Rep"},{"key":"4255_CR8","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.3390\/jcm9123918","volume":"9","author":"R Strawbridge","year":"2020","unstructured":"Strawbridge R, Marwood L, King S, Young AH, Pariante CM, Colasanti A, et al. Inflammatory proteins and clinical response to psychological therapy in patients with depression: an exploratory study. J Clin Med. 2020;9:3918.","journal-title":"J Clin Med"},{"key":"4255_CR9","doi-asserted-by":"publisher","first-page":"fcad231","DOI":"10.1093\/braincomms\/fcad231","volume":"5","author":"A Mudra Rakshasa-Loots","year":"2023","unstructured":"Mudra Rakshasa-Loots A. Depression and HIV: a scoping review in search of neuroimmune biomarkers. Brain Commun. 2023;5:fcad231.","journal-title":"Brain Commun"},{"key":"4255_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1557816","volume":"16","author":"SD Zaongo","year":"2025","unstructured":"Zaongo SD, Wu W, Chen Y. Pathogenesis of HIV-associated depression: contributing factors and underlying mechanisms. Front Psychiatry. 2025;16:1557816.","journal-title":"Front Psychiatry"},{"key":"4255_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03024-8","volume":"21","author":"W Balestri","year":"2024","unstructured":"Balestri W, Sharma R, da Silva VA, Bobotis BC, Curle AJ, Kothakota V, et al. Modeling the neuroimmune system in Alzheimer\u2019s and Parkinson\u2019s diseases. J Neuroinflammation. 2024;21:32.","journal-title":"J Neuroinflammation"},{"key":"4255_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.14336\/AD.2024.0214-1","volume":"16","author":"W Lu","year":"2024","unstructured":"Lu W, Wen J. Neuroinflammation and post-stroke depression: focus on the microglia and astrocytes. Aging Dis. 2024;16:394\u2013407.","journal-title":"Aging Dis"},{"key":"4255_CR13","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.1038\/s41380-021-01236-5","volume":"26","author":"A G\u00f6teson","year":"2021","unstructured":"G\u00f6teson A, Isgren A, Jonsson L, Sparding T, Smedler E, Pelanis A, et al. Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder. Mol Psychiatry. 2021;26:7446\u201353.","journal-title":"Mol Psychiatry"},{"key":"4255_CR14","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1038\/s41380-022-01724-2","volume":"27","author":"A Isgren","year":"2022","unstructured":"Isgren A, G\u00f6teson A, Holm\u00e9n-Larsson J, Pelanis A, Sellgren C, Joas E, et al. Cerebrospinal fluid proteomic study of two bipolar disorder cohorts. Mol Psychiatry. 2022;27:4568\u201374.","journal-title":"Mol Psychiatry"},{"key":"4255_CR15","doi-asserted-by":"crossref","first-page":"100989","DOI":"10.1016\/j.bbih.2025.100989","volume":"46","author":"F De Cillis","year":"2025","unstructured":"De Cillis F, Begni V, D\u2019Aprile I, Petrillo G, Riva MA, Annamaria Cattaneo A. Immune dysregulation and neuroinflammation in bipolar disorder: pathophysiological insights and therapeutic perspectives. Brain, Behavior, & Immunity \u2013 Health. 2025;46:100989.","journal-title":"Brain, Behavior, & Immunity \u2013 Health"},{"key":"4255_CR16","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.3390\/cimb46050275","volume":"46","author":"T Bagari\u0107","year":"2024","unstructured":"Bagari\u0107 T, Mihaljevi\u0107-Pele\u0161 A, Sko\u010di\u0107 Han\u017eek M, \u017divkovi\u0107 M, Kozmar A, Rogi\u0107 D. Serum levels of zinc, albumin, Interleukin-6 and CRP in patients with unipolar and bipolar depression: cross sectional study. Curr Issues Mol Biol. 2024;46:4533\u201350.","journal-title":"Curr Issues Mol Biol"},{"key":"4255_CR17","doi-asserted-by":"publisher","unstructured":"Sutantio EH, Octaviani ID Neuroinflammation in the pathogenesis of psychiatric disorder. Bulletin of Counseling and Psychotherapy 2025;7. https:\/\/doi.org\/10.51214\/bocp.v7i2.1341.","DOI":"10.51214\/bocp.v7i2.1341"},{"key":"4255_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446\u201357.","journal-title":"Biol Psychiatry"},{"key":"4255_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivim\u00e4ki M. Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206\u201315.","journal-title":"Brain Behav Immun"},{"key":"4255_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: from clinical significance to quantification. Adv Sci (Weinh). 2021;8:e2004433.","journal-title":"Adv Sci (Weinh)"},{"key":"4255_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100564","volume":"26","author":"MT Wijaya","year":"2022","unstructured":"Wijaya MT, Jin RR, Liu X, Zhang R, Lee TMC. Towards a multidimensional model of inflamed depression. Brain Behav Immun Health. 2022;26:100564.","journal-title":"Brain Behav Immun Health"},{"key":"4255_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/mp.2013.35","volume":"19","author":"M Kivim\u00e4ki","year":"2014","unstructured":"Kivim\u00e4ki M, Shipley MJ, Batty GD, Hamer M, Akbaraly TN, Kumari M, et al. Long-term inflammation increases risk of common mental disorder: a cohort study. Mol Psychiatry. 2014;19:149\u201350.","journal-title":"Mol Psychiatry"},{"key":"4255_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","volume":"70","author":"MK Wium-Andersen","year":"2013","unstructured":"Wium-Andersen MK, \u00d8rsted DD, Nielsen SF, Nordestgaard BG. Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry. 2013;70:176\u201384.","journal-title":"JAMA Psychiatry"},{"key":"4255_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41588-018-0309-3","volume":"51","author":"R Karlsson Linn\u00e9r","year":"2019","unstructured":"Karlsson Linn\u00e9r R, Biroli P, Kong E, Meddens SFW, Wedow R, Fontana MA, et al. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat Genet. 2019;51:245\u201357.","journal-title":"Nat Genet"},{"key":"4255_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajp.2017.01.025","volume":"27","author":"J Dean","year":"2017","unstructured":"Dean J, Keshavan M. The neurobiology of depression: an integrated view. Asian J Psychiatr. 2017;27:101\u201311.","journal-title":"Asian J Psychiatr"},{"key":"4255_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.iac.2009.02.002","volume":"29","author":"R Dantzer","year":"2009","unstructured":"Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29:247\u201364.","journal-title":"Immunol Allergy Clin North Am"},{"key":"4255_CR27","doi-asserted-by":"publisher","first-page":"16136","DOI":"10.1073\/pnas.1415191111","volume":"111","author":"GE Hodes","year":"2014","unstructured":"Hodes GE, Pfau ML, Leboeuf M, Golden SA, Christoffel DJ, Bregman D, et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci USA. 2014;111:16136\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4255_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.biopsych.2019.04.011","volume":"86","author":"F Cathomas","year":"2019","unstructured":"Cathomas F, Murrough JW, Nestler EJ, Han MH, Russo SJ. Neurobiology of resilience: interface between mind and body. Biol Psychiatry. 2019;86:410\u201320.","journal-title":"Biol Psychiatry"},{"key":"4255_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32:1\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4255_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015;72:268\u201375.","journal-title":"JAMA Psychiatry"},{"key":"4255_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","volume":"81","author":"D Enache","year":"2019","unstructured":"Enache D, Pariante CM, Mondelli V. Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun. 2019;81:24\u201340.","journal-title":"Brain Behav Immun"},{"key":"4255_CR32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41386-020-00948-6","volume":"46","author":"MA Nettis","year":"2021","unstructured":"Nettis MA, Lombardo G, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, et al. Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial. Neuropsychopharmacology. 2021;46:939\u201348.","journal-title":"Neuropsychopharmacology"},{"key":"4255_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","volume":"42","author":"J Steiner","year":"2008","unstructured":"Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 2008;42:151\u20137.","journal-title":"J Psychiatr Res"},{"key":"4255_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrn.2016.69","volume":"17","author":"ES Wohleb","year":"2016","unstructured":"Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci. 2016;17:497\u2013511.","journal-title":"Nat Rev Neurosci"},{"key":"4255_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.biopsych.2023.04.020","volume":"94","author":"KWF Scheepstra","year":"2023","unstructured":"Scheepstra KWF, Mizee MR, van Scheppingen J, Adelia A, Wever DD, Mason MRJ, et al. Microglia transcriptional profiling in major depressive disorder shows inhibition of cortical gray matter microglia. Biol Psychiatry. 2023;94:619\u201329.","journal-title":"Biol Psychiatry"},{"key":"4255_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2025.1598178","volume":"19","author":"X Xia","year":"2025","unstructured":"Xia X, Li K, Zou W, Wang L. The central role of microglia in major depressive disorder and its potential as a therapeutic target. Front Behav Neurosci. 2025;19:1598178.","journal-title":"Front Behav Neurosci"},{"key":"4255_CR37","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276\u20131290.e17.","journal-title":"Cell"},{"key":"4255_CR38","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1523\/JNEUROSCI.2394-15.2016","volume":"36","author":"DB McKim","year":"2016","unstructured":"McKim DB, Niraula A, Tarr AJ, Wohleb ES, Sheridan JF, Godbout JP. Neuroinflammatory dynamics underlie memory impairments after repeated social defeat. J Neurosci. 2016;36:2590\u2013604.","journal-title":"J Neurosci"},{"key":"4255_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2026.106607","volume":"184","author":"Y Wang","year":"2026","unstructured":"Wang Y, Xiong Z, Chen M, Zhu Z. Myelin damage in major depressive disorder: Insights from neuroimaging, molecular mechanisms, and therapeutic perspectives. Neurosci Biobehav Rev. 2026;184:106607.","journal-title":"Neurosci Biobehav Rev"},{"key":"4255_CR40","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.it.2020.07.004","volume":"41","author":"MV Sofroniew","year":"2020","unstructured":"Sofroniew MV. Astrocyte reactivity: subtypes, states, and functions in CNS innate immunity. Trends Immunol. 2020;41:758\u201370.","journal-title":"Trends Immunol"},{"key":"4255_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1\u201312.","journal-title":"Brain Behav Immun"},{"key":"4255_CR42","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41586-023-07015-2","volume":"626","author":"F Cathomas","year":"2024","unstructured":"Cathomas F, Lin HY, Chan KL, Li L, Parise LF, Alvarez J, et al. Circulating myeloid-derived MMP8 in stress susceptibility and depression. Nature. 2024;626:1108\u201315.","journal-title":"Nature"},{"key":"4255_CR43","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","volume":"20","author":"C Menard","year":"2017","unstructured":"Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20:1752\u201360.","journal-title":"Nat Neurosci"},{"key":"4255_CR44","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1037\/a0035302","volume":"140","author":"GM Slavich","year":"2014","unstructured":"Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140:774\u2013815.","journal-title":"Psychol Bull"},{"key":"4255_CR45","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1176\/ajp.2006.163.9.1630","volume":"163","author":"TW Pace","year":"2006","unstructured":"Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry. 2006;163:1630\u20133.","journal-title":"Am J Psychiatry"},{"key":"4255_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"4255_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020;25:131\u201347.","journal-title":"Mol Psychiatry"},{"key":"4255_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1596649","volume":"18","author":"A Yang","year":"2025","unstructured":"Yang A, He G, Song Y, Wen Y, Xia H, Gu S. Nfkbia-driven neuroinflammatory pathways mediate depression following spinal cord injury. Front Mol Neurosci. 2025;18:1596649.","journal-title":"Front Mol Neurosci"},{"key":"4255_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","volume":"48","author":"LG Appelbaum","year":"2023","unstructured":"Appelbaum LG, Shenasa MA, Stolz L, Daskalakis Z. Synaptic plasticity and mental health: methods, challenges and opportunities. Neuropsychopharmacology. 2023;48:113\u201320.","journal-title":"Neuropsychopharmacology"},{"key":"4255_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2025.107093","volume":"277","author":"AM Gabela","year":"2026","unstructured":"Gabela AM, Mthembu N, Hadebe S. Tryptophan metabolism in health and disease- implications for non-communicable diseases. Immunol Lett. 2026;277:107093.","journal-title":"Immunol Lett"},{"key":"4255_CR51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry. 2010;15:393\u2013403.","journal-title":"Mol Psychiatry"},{"key":"4255_CR52","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00424-019-02310-2","volume":"471","author":"A Verkhratsky","year":"2019","unstructured":"Verkhratsky A, Rodrigues JJ, Pivoriunas A, Zorec R, Semyanov A. Astroglial atrophy in Alzheimer\u2019s disease. Pflugers Arch. 2019;471:1247\u201361.","journal-title":"Pflugers Arch"},{"key":"4255_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0241-4","volume":"8","author":"E Haroon","year":"2018","unstructured":"Haroon E, Chen X, Li Z, Patel T, Woolwine BJ, Hu XP, et al. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia. Transl Psychiatry. 2018;8:189.","journal-title":"Transl Psychiatry"},{"key":"4255_CR54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jad.2022.12.021","volume":"323","author":"S Meshkat","year":"2023","unstructured":"Meshkat S, Ho RC, Cao B, Teopiz KM, Rosenblat JD, Rhee TG, et al. Biomarkers of ketamine\u2019s antidepressant effect: an umbrella review. J Affect Disord. 2023;323:598\u2013606.","journal-title":"J Affect Disord"},{"key":"4255_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/npp.2016.198","volume":"42","author":"A Danese","year":"2017","unstructured":"Danese A, J Lewis S. Psychoneuroimmunology of early-life stress: the hidden wounds of childhood trauma?. Neuropsychopharmacology. 2017;42:99\u2013114.","journal-title":"Neuropsychopharmacology"},{"key":"4255_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.01.017","volume":"58","author":"V Chesnokova","year":"2016","unstructured":"Chesnokova V, Pechnick RN, Wawrowsky K. Chronic peripheral inflammation, hippocampal neurogenesis, and behavior. Brain Behav Immun. 2016;58:1\u20138.","journal-title":"Brain Behav Immun"},{"key":"4255_CR57","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbi.2017.05.006","volume":"65","author":"A Borsini","year":"2017","unstructured":"Borsini A, Alboni S, Horowitz MA, Tojo LM, Cannazza G, Su KP, et al. Rescue of IL-1\u03b2-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants. Brain Behav Immun. 2017;65:230\u20138.","journal-title":"Brain Behav Immun"},{"key":"4255_CR58","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/mp.2012.144","volume":"18","author":"F Lamers","year":"2013","unstructured":"Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013;18:692\u20139.","journal-title":"Mol Psychiatry"},{"key":"4255_CR59","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","volume":"25","author":"R Strawbridge","year":"2015","unstructured":"Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, et al. Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol. 2015;25:1532\u201343.","journal-title":"Eur Neuropsychopharmacol"},{"key":"4255_CR60","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2024.787","volume":"10","author":"W Paganin","year":"2024","unstructured":"Paganin W, Signorini S. Inflammatory biomarkers in depression: scoping review. BJPsych Open. 2024;10:e165.","journal-title":"BJPsych Open"},{"key":"4255_CR61","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/ijms23031616","volume":"23","author":"L Orsolini","year":"2022","unstructured":"Orsolini L, Pompili S, Tempia Valenta S, Salvi V, Volpe U. C-reactive protein as a biomarker for major depressive disorder?. Int J Mol Sci. 2022;23:1616.","journal-title":"Int J Mol Sci"},{"key":"4255_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31\u201341.","journal-title":"JAMA Psychiatry"},{"key":"4255_CR63","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","volume":"76","author":"RS McIntyre","year":"2019","unstructured":"McIntyre RS, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, et al. Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial. JAMA Psychiatry. 2019;76:783\u201390.","journal-title":"JAMA Psychiatry"},{"key":"4255_CR64","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","volume":"7","author":"MI Husain","year":"2020","unstructured":"Husain MI, Chaudhry IB, Khoso AB, Husain MO, Hodsoll J, Ansari MA, et al. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial. Lancet Psychiatry. 2020;7:515\u201327.","journal-title":"Lancet Psychiatry"},{"key":"4255_CR65","doi-asserted-by":"publisher","first-page":"15318","DOI":"10.1007\/s12035-025-05177-w","volume":"62","author":"YD Liu","year":"2025","unstructured":"Liu YD, Chang YH, Xie XT, Wang XY, Ma HY, Liu MC, et al. PET imaging unveils neuroinflammatory mechanisms in psychiatric disorders: from microglial activation to therapeutic innovation. Mol Neurobiol. 2025;62:15318\u201335.","journal-title":"Mol Neurobiol"},{"key":"4255_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNF.0000000000000618","volume":"48","author":"H Huang","year":"2025","unstructured":"Huang H, Zou Z, Chen B. Efficacy of minocycline in depression: a systematic review and meta-analysis. Clin Neuropharmacol. 2025;48:1\u20136.","journal-title":"Clin Neuropharmacol"},{"key":"4255_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01189-3","volume":"11","author":"C Smith","year":"2021","unstructured":"Smith C, Trageser KJ, Wu H, Herman FJ, Iqbal UH, Sebastian-Valverde M, et al. Anxiolytic effects of NLRP3 inflammasome inhibition in a model of chronic sleep deprivation. Transl Psychiatry. 2021;11:52.","journal-title":"Transl Psychiatry"},{"key":"4255_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107011","volume":"213","author":"YT Zhong","year":"2025","unstructured":"Zhong YT, Pi C, Zuo Y, Wei Y, Li W, Jiang YQ, et al. The P2X7 receptor in depression: novel insights and therapeutic implications. Neurobiol Dis. 2025;213:107011.","journal-title":"Neurobiol Dis"},{"key":"4255_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110903","volume":"124","author":"D Xu","year":"2023","unstructured":"Xu D, Xu Y, Gao X, Yan M, Zhang C, Wu X, et al. Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats. Int Immunopharmacol. 2023;124:110903.","journal-title":"Int Immunopharmacol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04255-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04255-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04255-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:02:26Z","timestamp":1790560946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04255-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4255"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04255-4","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Preparation of this manuscript involved the use of an AI-assisted writing tool (Grammarly) for drafting and editing support. The figure was created with AI assistance (ChatGPT). In accordance with Springer Nature policy and the journal\u2019s authorship guidelines, a statement has been added to the Acknowledgments section. All scientific content, data interpretation, literature selection, and conclusions are the sole responsibility of the authors. The AI tool does not meet authorship criteria and is not listed as an author.","order":2,"name":"Ethics","label":"AI disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Preparation of this manuscript involved using an AI-assisted writing tool (Grammarly) for language correction and editing support and ChatGPT to generate the Figure. All scientific content, data interpretation, literature selection, and conclusions are the sole responsibility of the authors. The AI tools do not meet authorship criteria and are not listed as authors.","order":3,"name":"Ethics","label":"AI assistance","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"489"}}